Phison Included in the S&P Global Sustainability Yearbook for Four Consecutive Years

Phison has again been recognized in the S&P Global Sustainability Yearbook 2026, marking its 4th consecutive inclusion in this prestigious global ranking. Phison stood out among 421 companies in the Semiconductors & Semiconductor Equipment industry this year, demonstrating our outstanding performance in ESG. In the future, Phison will continue to improve various sustainable projects, focus […]
Phison Included in the S&P Global Sustainability Yearbook for Three Consecutive Years

Phison has again been recognized in the S&P Global Sustainability Yearbook 2025, marking its third consecutive inclusion in this prestigious global ranking. In the future, Phison will continue to improve various sustainable projects, focus on the impact that the technology industry can bring, and create sustainable shared value. Note: The Global Sustainability Yearbook is one […]
Phison Included in the S&P Global Sustainability Yearbook for Two Consecutive Years

Phison has participated in the Global Corporate Sustainability Assessment(CSA) led by S&P Global, an international sustainability rating agency, for many years in a row. Following 2023, we were once again selected as a member of the “2024 Sustainability Yearbook” this year, representing the recognition for our continuous efforts in ESG. In the future, Phison will […]
Phison was selected as a member of the S&P Global 2023 Sustainability Yearbook

Phison has participated in the Global Corporate Sustainability Assessment(CSA) led by S&P Global, an international sustainability rating agency, for many years in a row. This year, Phison was selected as a member of the ” 2023 Sustainability Yearbook ” for the first time, representing the recognition for our efforts in ESG. The Global Sustainability Yearbook […]
2021 Corporate Governance Evaluation Results Announced Phison ranks in the top 6% to 20%

The results of the corporate governance evaluation[1] in 2021 were released. Phison continues to be ranked in the top 6% to 20% among 109 OTC companies. However, the scores improved significantly compared with last year, and were also much higher than the average scores of the top 6% to 20%[2]. The effectiveness of the internal implementation […]